Fecal Occult Blood Test Performance Indicators in Warfarin-Treated Patients
Authors:
- Idit LaviILIdit Lavi
- Gad RennertGRGad Rennert
- Ronit AlmogRARonit Almog
- 1 February 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 53 (2) , 224-229
Abstract
Antithrombotic drugs such as warfarin cause a general increase in bleeding tendency and therefore could influence fecal occult blood test results. A population-based retrospective cohort study was conducted to investigate the performance of the fecal occult blood test for colorectal cancer screening in patients taking warfarin. The study population included 1356 tests performed in warfarin-treated patients and 64,088 tests in those not taking antithrombotics. Data on lower gastrointestinal evaluation were collected on 425 cases with a positive fecal occult blood test: all positives on warfarin and positive cases of a subsample of those tests in the group without antithrombotic treatment. The positivity rate of the fecal occult blood test in the warfarin group was found to be doubled (7.7% (95%CI, 6.3%-9.2%)) compared with those not taking antithrombotics (3.6% (95%CI, 3.4%-3.7%)) (P <.0001). No significant difference in the positive predictive value for carcinoma and significant adenomas was found comparing the warfarin group to the no-antithrombotic group. The detection rates of both clinically significant adenomas and findings not indicative of significant neoplasia were increased in the warfarin group (8.9/1000 and 32.5/1000 respectively) compared with the no-antithrombotic group (4.0/1000 and 11.3/1000) (P = .02 and P <.0001 respectively), whereas that of carcinoma was not found to be different (3.7/1000 in the warfarin group vs 3.3/1000, P = .85). Fecal occult blood test screening in warfarin users results in a higher, yet reasonable, positivity load and in a higher detection of premalignant lesions than in the general population. We consider fecal occult blood test screening appropriate for the warfarin-taking population.Keywords
This publication has 15 references indexed in Scilit:
- Colorectal cancer screening: A comparison of 35 initiatives in 17 countriesInternational Journal of Cancer, 2007
- Screening for colorectal cancer using the faecal occult blood test, HemoccultCochrane Database of Systematic Reviews, 2007
- Guidelines for Colonoscopy Surveillance after Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society,CA: A Cancer Journal for Clinicians, 2006
- Positive Predictive Value of Fecal Occult Blood Testing in Persons Taking WarfarinAmerican Journal of Gastroenterology, 2005
- Anticoagulation InterruptusCirculation, 2004
- Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trialGut, 2002
- Fecal Occult Blood Test Screening for Colorectal CancerGastrointestinal Endoscopy Clinics of North America, 2002
- Bleeding During Warfarin and Aspirin Therapy in Patients With Atrial FibrillationArchives of internal medicine (1960), 1999
- Significance of occult gastrointestinal bleeding during anticoagulation therapyThe American Journal of Medicine, 1987
- Fecal Blood Levels in Health and DiseaseNew England Journal of Medicine, 1985